Computational drug design approach has a great potential in accelerating the drug discovery process. Structure-based drug design and ligand-based drug design are the two broad classes of computational drug design. Cancer is a class of highly complex diseases involving multiple genes and multiple cross-talks between signaling networks. Cancer cells may be developed from inherited defects or acquired damages of DNA. However, many cancers are resistant to treatment, and metastasis of cancers makes the disease even more intractable. Secondary malignancies are frequently observed after cancer chemotherapy. The call for more effective cancer therapy is obligatory. Using drug-cocktails that combine multiple anti-cancer agents working in different mechanisms has been a standard treatment of cancers to overcome the drug resistance problem. More recently, design of multiple ligands (may be more easily understood as “multiple target ligands”), i.e., single agents that target multiple biomolecules in a rational manner, receives increasing attention. Some recent methodological developments on computational drug design are reviewed, and a few recent drug design efforts in cancer is summarized.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Talath Fatima is a Pharmacy graduate Student at Deccan School of Pharmacy, Hyderabad.She serves as one of the youngest Editorial Advisor in four Pharmaceutical journals.Dr. Osman Ahmed is an elite Professor in Pharmaceutical Chemistry and Vice-Principal of Deccan School of Pharmacy.He has done appreciable research work in the field of Pharmacy.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: PBShop.store US, Wood Dale, IL, USA
PAP. Zustand: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bestandsnummer des Verkäufers L0-9786208472672
Anzahl: Mehr als 20 verfügbar
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
PAP. Zustand: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bestandsnummer des Verkäufers L0-9786208472672
Anzahl: Mehr als 20 verfügbar
Anbieter: California Books, Miami, FL, USA
Zustand: New. Bestandsnummer des Verkäufers I-9786208472672
Anzahl: Mehr als 20 verfügbar
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 104 pp. Englisch. Bestandsnummer des Verkäufers 9786208472672
Anzahl: 2 verfügbar
Anbieter: CitiRetail, Stevenage, Vereinigtes Königreich
Paperback. Zustand: new. Paperback. Computational drug design approach has a great potential in accelerating the drug discovery process. Structure-based drug design and ligand-based drug design are the two broad classes of computational drug design. Cancer is a class of highly complex diseases involving multiple genes and multiple cross-talks between signaling networks. Cancer cells may be developed from inherited defects or acquired damages of DNA. However, many cancers are resistant to treatment, and metastasis of cancers makes the disease even more intractable. Secondary malignancies are frequently observed after cancer chemotherapy. The call for more effective cancer therapy is obligatory. Using drug-cocktails that combine multiple anti-cancer agents working in different mechanisms has been a standard treatment of cancers to overcome the drug resistance problem. More recently, design of multiple ligands (may be more easily understood as "multiple target ligands"), i.e., single agents that target multiple biomolecules in a rational manner, receives increasing attention. Some recent methodological developments on computational drug design are reviewed, and a few recent drug design efforts in cancer is summarized. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Bestandsnummer des Verkäufers 9786208472672
Anzahl: 1 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. Print on Demand. Bestandsnummer des Verkäufers 408584168
Anzahl: 4 verfügbar
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. Bestandsnummer des Verkäufers 26405651511
Anzahl: 4 verfügbar
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Computational drug design approach has a great potential in accelerating the drug discovery process. Structure-based drug design and ligand-based drug design are the two broad classes of computational drug design. Cancer is a class of highly complex diseases involving multiple genes and multiple cross-talks between signaling networks. Cancer cells may be developed from inherited defects or acquired damages of DNA. However, many cancers are resistant to treatment, and metastasis of cancers makes the disease even more intractable. Secondary malignancies are frequently observed after cancer chemotherapy. The call for more effective cancer therapy is obligatory. Using drug-cocktails that combine multiple anti-cancer agents working in different mechanisms has been a standard treatment of cancers to overcome the drug resistance problem. More recently, design of multiple ligands (may be more easily understood as 'multiple target ligands'), i.e., single agents that target multiple biomolecules in a rational manner, receives increasing attention. Some recent methodological developments on computational drug design are reviewed, and a few recent drug design efforts in cancer is summarized.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 104 pp. Englisch. Bestandsnummer des Verkäufers 9786208472672
Anzahl: 1 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Computational drug design approach has a great potential in accelerating the drug discovery process. Structure-based drug design and ligand-based drug design are the two broad classes of computational drug design. Cancer is a class of highly complex diseases involving multiple genes and multiple cross-talks between signaling networks. Cancer cells may be developed from inherited defects or acquired damages of DNA. However, many cancers are resistant to treatment, and metastasis of cancers makes the disease even more intractable. Secondary malignancies are frequently observed after cancer chemotherapy. The call for more effective cancer therapy is obligatory. Using drug-cocktails that combine multiple anti-cancer agents working in different mechanisms has been a standard treatment of cancers to overcome the drug resistance problem. More recently, design of multiple ligands (may be more easily understood as 'multiple target ligands'), i.e., single agents that target multiple biomolecules in a rational manner, receives increasing attention. Some recent methodological developments on computational drug design are reviewed, and a few recent drug design efforts in cancer is summarized. Bestandsnummer des Verkäufers 9786208472672
Anzahl: 1 verfügbar
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. PRINT ON DEMAND. Bestandsnummer des Verkäufers 18405651517
Anzahl: 4 verfügbar